An overview of the EORTC breast cancer cooperative group's activities
- 31 December 1983
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (12) , 1665-1669
- https://doi.org/10.1016/0277-5379(83)90149-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- N-(Phosphonacetyl)-l-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative groupEuropean Journal of Cancer and Clinical Oncology, 1982
- Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study.BMJ, 1975
- Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.BMJ, 1975
- Clinical trial of nafoxidine, an oestrogen antagonist in advanced breast cancerPublished by Elsevier ,1972
- Clinical trial of the cyclic imide 1-(Morpholinomethyl)-4-phtalimido-piperidindione-2,6 (CG 603) in advanced breast cancerPublished by Elsevier ,1972
- Clinical trial of 2-Br-α-ergocryptine (CB154) in advanced breast cancerPublished by Elsevier ,1972
- The antitumoral activity of some derivatives of 6-aminochrysenePublished by Elsevier ,1970
- Essai clinique du phénol bis (2-chloroéthyl) carbamate d'oestradiol dans le cancer mammaire en phase avancéeEuropean Journal of Cancer (1965), 1969
- Induction par le 6-aminochrysène de rémission du cancer du sein en phase avancée chez la femmeEuropean Journal of Cancer (1965), 1967